Next Generation Immunotherapies: from Innovative Approaches to Overcoming Resistance and Beyond
Conference Officer: Chris Iliffe (christopher.iliffe@eacr.org)
Join us online on 24 and 25 February 2026 to explore cutting-edge developments in immunotherapy, ranging from basic research to clinical applications, with a particular focus on innovative therapeutic strategies.
The programme will include invited talks from leading scientists in areas such as novel NK, T and myeloid cell therapies, mRNA therapies, and new combinatorial immune checkpoint blockade strategies. It will provide a broad overview and detailed knowledge of novel targets and new therapeutic strategies in this field.
If your work centres on any of the topics mentioned above, you may be able to present it at our conference! Submit an abstract by 12 January 2026 for a chance to have your work featured as a Proffered Paper or in a Flash Talk presentation! Participant registration closes on 02 February 2026.
Speakers: Joaquin Arribas (Hospital del Mar Research Institute, Spain) | Arianna Calcinotto (Institute of Oncology Research, Switzerland) | Alena Gros (VHIO, Spain) | Marleen Kok (NKI, Netherlands) | Pablo Menendez (Josep Carreras Leukaemia Research Institute, Spain) | Raymond Schiffelers (UMC Utrecht, Netherlands) | Eric Vivier (Center of Immunology at Marseille-Luminy, France) | Nathan West (Genentech, USA)
Keywords: cancer research, oncology, cancer immunotherapy, next-gen approaches to cancer therapies, cancer resistance, overcoming cancer resistance, novel NK cell therapy, novel T-cell therapy, novel myeloid cell therapy, mRNA therapy, cytokine targeting, personalised immunotherapies, basic cancer research, translational cancer research, pre-clinical cancer research, clinical applications
